These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18524824)

  • 1. Impaired naive and memory B-cell responsiveness to TLR9 stimulation in human immunodeficiency virus infection.
    Jiang W; Lederman MM; Mohner RJ; Rodriguez B; Nedrich TM; Harding CV; Sieg SF
    J Virol; 2008 Aug; 82(16):7837-45. PubMed ID: 18524824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
    Abu-Rish EY; Amrani Y; Browning MJ
    Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG oligonucleotides enhance proliferative and effector responses of B Cells in HIV-infected individuals.
    Malaspina A; Moir S; DiPoto AC; Ho J; Wang W; Roby G; O'Shea MA; Fauci AS
    J Immunol; 2008 Jul; 181(2):1199-206. PubMed ID: 18606673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals.
    Martinson JA; Tenorio AR; Montoya CJ; Al-Harthi L; Gichinga CN; Krieg AM; Baum LL; Landay AL
    Immunology; 2007 Apr; 120(4):526-35. PubMed ID: 17343615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A threshold level of TLR9 mRNA predicts cellular responsiveness to CpG-ODN in haematological and non-haematological tumour cell lines.
    Assaf A; Esteves H; Curnow SJ; Browning MJ
    Cell Immunol; 2009; 259(1):90-9. PubMed ID: 19573862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR9 signaling failure renders Peyer's patch regulatory B cells unresponsive to stimulation with CpG oligodeoxynucleotides.
    Booth JS; Arsenault R; Napper S; Griebel PJ; Potter AA; Babiuk LA; Mutwiri GK
    J Innate Immun; 2010; 2(5):483-94. PubMed ID: 20551621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells.
    He W; Zhang Y; Zhang J; Yu Q; Wang P; Wang Z; Smith AJ
    J Endod; 2012 Jun; 38(6):780-5. PubMed ID: 22595112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of human B cell activation by TLR7 and TLR9 agonists.
    Hanten JA; Vasilakos JP; Riter CL; Neys L; Lipson KE; Alkan SS; Birmachu W
    BMC Immunol; 2008 Jul; 9():39. PubMed ID: 18652679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bruton's tyrosine kinase separately regulates NFkappaB p65RelA activation and cytokine interleukin (IL)-10/IL-12 production in TLR9-stimulated B Cells.
    Lee KG; Xu S; Wong ET; Tergaonkar V; Lam KP
    J Biol Chem; 2008 Apr; 283(17):11189-98. PubMed ID: 18276597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA.
    Wagner M; Poeck H; Jahrsdoerfer B; Rothenfusser S; Prell D; Bohle B; Tuma E; Giese T; Ellwart JW; Endres S; Hartmann G
    J Immunol; 2004 Jan; 172(2):954-63. PubMed ID: 14707068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primate immune responses to HIV-1 Env formulated in the saponin-based adjuvant AbISCO-100 in the presence or absence of TLR9 co-stimulation.
    Martinez P; Sundling C; O'Dell S; Mascola JR; Wyatt RT; Karlsson Hedestam GB
    Sci Rep; 2015 Mar; 5():8925. PubMed ID: 25762407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
    Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.
    Hornung V; Rothenfusser S; Britsch S; Krug A; Jahrsdörfer B; Giese T; Endres S; Hartmann G
    J Immunol; 2002 May; 168(9):4531-7. PubMed ID: 11970999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR9 activation is defective in common variable immune deficiency.
    Cunningham-Rundles C; Radigan L; Knight AK; Zhang L; Bauer L; Nakazawa A
    J Immunol; 2006 Feb; 176(3):1978-87. PubMed ID: 16424230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
    J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could DNA-reactive B lymphocytes be activated through HIV-1 DNA-stimulation involving BCR/TLR-9 pathway to yield antibodies targeting viral DNA?
    Norelli S
    Med Hypotheses; 2014 Dec; 83(6):659-63. PubMed ID: 25441838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.
    Giordani L; Sanchez M; Libri I; Quaranta MG; Mattioli B; Viora M
    J Leukoc Biol; 2009 Aug; 86(2):261-71. PubMed ID: 19401392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation and inhibition of FVIII-specific memory B-cell responses by CpG-B (ODN 1826), a ligand for Toll-like receptor 9.
    Allacher P; Baumgartner CK; Pordes AG; Ahmad RU; Schwarz HP; Reipert BM
    Blood; 2011 Jan; 117(1):259-67. PubMed ID: 20889922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The agonists of TLR4 and 9 are sufficient to activate memory B cells to differentiate into plasma cells in vitro but not in vivo.
    Richard K; Pierce SK; Song W
    J Immunol; 2008 Aug; 181(3):1746-52. PubMed ID: 18641311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A; Calcaterra C; Mènard S; Balsari A
    J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.